The first phase of the clinical trial of an Egyptian-made vaccine produced with raw materials at the National Research Center started Sunday, announced Ministry of Health spokesperson Hossam Abdel Ghaffar. Abdel Ghaffar said that there was still a rise in the number of coronavirus infections across Egypt. The occupancy rate of ventilators is less than 30 percent, he added. Abdel Ghaffar stated that the number of those who received the first or second doses of coronavirus vaccine in Egypt is about 40 million people. He added that the Health Ministry aims for 40 million more people to receive two doses of the vaccine at the end of December.
